We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+0.55%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$48B
AUM Growth
-$1.59B
(-3.2%)
Cap. Flow
-$1.46B
Cap. Flow
% of AUM
-3.05%
Top 10 Holdings %
Top 10 Hldgs %
24.06%
Holding
1,904
New
84
Increased
534
Reduced
502
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$60.6M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$50.8M |
| 3 |
Mastercard
MA
|
+$43.1M |
| 4 |
Analog Devices
ADI
|
+$40.3M |
| 5 |
Broadcom
AVGO
|
+$40.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$92.3M |
| 2 |
NVIDIA
NVDA
|
+$92.1M |
| 3 |
Eli Lilly
LLY
|
+$80.8M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$74.2M |
| 5 |
Microsoft
MSFT
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.14% |
| 2 | Financials | 15.08% |
| 3 | Healthcare | 14.69% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Communication Services | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Asbury Automotive
ABG
$4.49B
| $3.53M | 0.01% |
17,934
| – | – |
|
|
HZNP
802
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $3.53M | 0.01% |
32,206
+24,997
| +347% | +$2.6M |
|
803
Silgan Holdings
SLGN
$5.07B
| $3.51M | 0.01% |
91,508
-840
| -0.9% | -$34.2K |
|
804
3D Systems Corp
DDD
$412M
| $3.51M | 0.01% |
127,243
+9,900
| +8% | +$293K |
|
805
Public Service Enterprise Group
PEG
$39.3B
| $3.51M | 0.01% |
57,566
-85,609
| -60% | -$5.35M |
|
806
Bloomin' Brands
BLMN
$736M
| $3.5M | 0.01% |
140,100
| – | – |
|
807
Tapestry
TPR
$30.5B
| $3.5M | 0.01% |
94,435
+7,078
| +8% | +$291K |
|
808
Enovis
ENOV
$1.7B
| $3.49M | 0.01% |
44,185
+2,469
| +6% | +$198K |
|
809
Bank of Hawaii
BOH
$3.16B
| $3.48M | 0.01% |
42,351
+3,985
| +10% | +$330K |
|
810
NIO
NIO
$11.7B
| $3.46M | 0.01% |
97,100
+3,550
| +4% | +$146K |
|
811
T. Rowe Price
TROW
$26.1B
| $3.46M | 0.01% |
17,571
-649
| -4% | -$137K |
|
812
Novavax
NVAX
$1.21B
| $3.45M | 0.01% |
16,635
+6,231
| +60% | +$1.37M |
|
813
CDW
CDW
$18.4B
| $3.44M | 0.01% |
18,915
-18,391
| -49% | -$3.47M |
|
814
Genpact
G
$5.87B
| $3.43M | 0.01% |
72,150
+27,305
| +61% | +$1.36M |
|
815
Timken Company
TKR
$9.72B
| $3.42M | 0.01% |
52,304
-7,655
| -13% | -$569K |
|
816
Diodes
DIOD
$3.69B
| $3.42M | 0.01% |
37,769
| – | – |
|
817
Avantor
AVTR
$8.48B
| $3.42M | 0.01% |
83,536
+49,992
| +149% | +$1.95M |
|
818
Kemper
KMPR
$1.82B
| $3.42M | 0.01% |
51,134
| – | – |
|
819
Parker-Hannifin
PH
$125B
| $3.41M | 0.01% |
12,180
-1,110
| -8% | -$330K |
|
|
JBTM
820
JBT Marel
JBTM
$7.59B
| $3.39M | 0.01% |
24,119
| – | – |
|
821
Cracker Barrel
CBRL
$1.2B
| $3.37M | 0.01% |
24,101
| – | – |
|
822
Murphy USA
MUSA
$11.1B
| $3.36M | 0.01% |
20,100
| – | – |
|
823
Merit Medical Systems
MMSI
$4.67B
| $3.35M | 0.01% |
46,720
| – | – |
|
824
Denali Therapeutics
DNLI
$3.82B
| $3.35M | 0.01% |
66,348
+24,406
| +58% | +$1.38M |
|
825
Kulicke & Soffa
KLIC
$4.76B
| $3.33M | 0.01% |
57,174
| – | – |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Ensign Peak Advisors held 1,904 positions worth $48B, down 3.2% from $49.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ensign Peak Advisors withdrew a net $1.46B in Q3 2021, closing 55 positions and reducing 502 holdings. Its most notable exit was Root, an estimated $29.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ensign Peak Advisors opened a new position in State Street SPDR S&P Biotech ETF worth $37.7M.
- Ensign Peak Advisors's largest Q3 2021 buy was State Street SPDR S&P Biotech ETF: 300,000 shares worth $37.7M.
- Ensign Peak Advisors added most to AbbVie in Q3 2021, an estimated $60.6M increase.
- Ensign Peak Advisors's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $92.3M.
- Ensign Peak Advisors fully exited Root in Q3 2021, selling an estimated $29.6M.
- Ensign Peak Advisors's ten largest holdings make up 24% of its $48B portfolio in Q3 2021.
- Ensign Peak Advisors opened 84 new positions and closed 55 in Q3 2021.
- Ensign Peak Advisors's portfolio value fell 3.2% quarter-over-quarter to $48B.
Based on Ensign Peak Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.